Market revenue in 2023 | USD 15,465.4 million |
Market revenue in 2030 | USD 29,596.2 million |
Growth rate | 9.7% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Development, Contract Manufacturing |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 82.23% in 2023. Horizon Databook has segmented the Canada healthcare contract development and manufacturing organization market based on contract development, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing investments in CDMOs in the country are anticipated to propel the market. For instance, in January 2020, Piramal Pharma Solutions, an Indian pharmaceutical firm, invested nearly USD 17 million (CAD 25 million) in its Aurora-based facility to establish a new API manufacturing unit.
Supportive government initiatives are anticipated to further facilitate market growth in the country. In March 2019, the Canadian government offered around USD 28 million to Bio Vectra, a Canadian CDMO, to facilitate the expansion of its biopharmaceutical manufacturing capabilities.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada healthcare contract development and manufacturing organization market , including forecasts for subscribers. This country databook contains high-level insights into Canada healthcare contract development and manufacturing organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account